Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adults With NASH and T2DM

NCT03656744 is registered in ClinicalTrials.gov with HighTide Therapeutics (Hong Kong) Limited as lead sponsor.

NCT NCT03656744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03656744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adults With NASH and T2DM
Lead sponsor
HighTide Therapeutics (Hong Kong) Limited
Phase
Phase 2
Overall status
Completed
Start date
November 26, 2018
Completion date
March 9, 2020
Enrollment
101 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system diseases, fatty liver, nonalcoholic, nafld, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes mellitus (t2dm)